SCHYLER WEBBER: Open Payments
NPI 1184406142 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$401 in 19 payments from 9 companies in 2025. Trend: 2023 $230 · 2024 $864 · 2025 $401
Food & beverage: $401
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 3 | $72 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| Janssen Pharmaceuticals, Inc | 3 | $63 |
| Axsome Therapeutics, Inc. | 3 | $61 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $36 |
| Lundbeck LLC | 1 | $25 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Tris Pharma Inc | 1 | $15 |
Products named: REXULTI, ARISTADA, SPRAVATO, Auvelity, COBENFY, CAPLYTA, TRINTELLIX, Dyanavel XR.
Industry payments across TN — which companies pay providers there.
